State audit reveals oversight failures in Massachusetts cannabis regulation, exposing testing lapses, financial errors, and risks to industry equity.

Research shows young adults using high-potency cannabis may not reduce dose. Clear labeling and harm-reduction education can improve safer use.

A large federally funded preprint shows marijuana users aged 44–81 have enhanced cognitive function and younger brain patterns—but causality remains unproven.

Pain, stress, and multiple chronic conditions drive cannabis use—highlighting urgent needs for harm-reduction strategies.

Cannabinoids like CBD and CBDV show promising antifungal activity, offering a safe, effective alternative for treating drug-resistant fungal infections.

New research highlights cannabinoid therapy, specifically combining cannabinol (CBN) with exemestane, as a promising advancement in treating estrogen receptor-positive breast cancer.

THCP, an ultra-potent cannabinoid discovered in 2019, is reshaping cannabis science with its extraordinary receptor affinity and groundbreaking therapeutic potential.

Immigrant women are the backbone of the cannabis industry, yet face widespread exploitation fueled by legal gaps, gender bias, and immigration vulnerabilities.

Cannabis offers a promising, research-backed approach to managing multiple sclerosis symptoms, addressing pain, spasticity, inflammation, and fatigue where conventional treatments fall short

Public perception is shifting as more Americans recognize cannabis as a safer alternative to alcohol, driving changes in consumption, policy, and cultural acceptance.

Chinese-linked illegal marijuana operations in Maine are exploiting regulatory gaps, undermining the legal cannabis market, and generating billions through organized crime, prompting urgent calls for enforcement action.